Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.
Brune MM, Stüssi G, Lundberg P, Vela V, Heim D, Manz MG, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Grobholz R, Fehr M, Cogliatti S, Ossenkoppele GJ, Löwenberg B, Rudolf CB, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK).
Brune MM, et al. Among authors: haralambieva e.
Ann Hematol. 2021 May;100(5):1169-1179. doi: 10.1007/s00277-021-04467-2. Epub 2021 Mar 2.
Ann Hematol. 2021.
PMID: 33704530
Free PMC article.
Clinical Trial.